Premium
The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus
Author(s) -
MENAGÉ H. DU P.,
NORRIS P.G.,
HAWK J.L.M.,
GREAVES M.W.
Publication year - 1993
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1993.tb03520.x
Subject(s) - medicine , psoralen , dermatology , dna , biology , genetics
Summary Psoralen photochemotherapy (PUVA) was effective in the treatment of five patients with aquagenic pruritus, associated in one with polycythaemia rubra vera and in another with the myelodysplastic syndrome. Relapse occurred within 2–24 weeks when treatment was discontinued. Maintenance therapy or a further course of PUVA was necessary to maintain remission. This requirement may limit the value of the therapy.